Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

330,000 Mazal Tovs

The loudspeaker announced the arrival of the bride. Guests rushed outside to the chuppah (wedding canopy) under the clear night sky in the Judean Hills at the Neve Ilan wedding venue. Every wedding is exciting, but tonight's is thrilling because 13 years ago, the young woman being married-- Adi Hudja--was on the verge of death in the trauma center at Hadassah University Hospital.


Adi and new husband Eliran Peretz

Adi and Prof. Rivkind

Thirteen years ago, Adi was scheduled to have her leg amputated. Now, she is walking easily down the aisle. Guests are applauding.

“Did you ever think you’d see her walking like this down the aisle?” whispers Barbara Sofer, Hadassah’s Israel Director of Public Relations, to the man standing to her left.

He can’t speak; he shakes his head “no.” This is Prof. Iri Liebergall, the head of Orthopedics at Hadassah, who saved her leg.

Standing closer to the chuppah is Prof. Avi Rivkind, head of the Trauma Unit. “Her cousin said I promised I’d dance with Adi at her wedding,” he says with wonder. Prof. Rivkind saved her life.

December 1, 2001 was a cold, clear winter night in Jerusalem. After Shabbat, Adi, then 13, and two cousins went downtown to Ben Yehudah Street for some fun. Just as they were about to return home, one of the cousins decided to get ice cream. Adi and cousin Racheli were waiting for her to return when a suicide bomber exploded next to Adi. That night, two terrorists and a car bomb exploded downtown killing 13 people, wounding hundreds.

Racheli was lightly injured. Adi had devastating injuries--shrapnel throughout her body, but mostly in her legs. She was rushed to Hadassah. The bleeding was so profuse that no matter how much blood she was given, she seemed to be bleeding to death. Doctors speculated that the nuts and bolts that had penetrated her skinny body had been soaked in rat poison or a similar substance to increase the amount of bleeding.

Her body temperature was dropping. That’s when Trauma Surgeon Prof. Rivkind decided to try the very expensive experimental drug, Nova 7. It had been developed for hemophiliacs, and it wasn’t supposed to be used for trauma victims.

But thanks to the Nova 7, the bleeding slowed. He gave her another dose.

The bleeding stopped.

Prof. Liebergall had been in Europe at a conference when he heard about the blast in Jerusalem. He headed for the airport to come home. When he landed early Sunday morning, he went straight to the hospital. He examined Adi. His staff thought she needed to have a leg amputated in order to save her life. Her mother had given her consent with a heavy heart. ”Anything to save my daughter,” she said.

“This was a dilemma for me,” said Prof Liebergall. “A dilemma means that you don’t know if you have the correct answer, but I felt we could save the limb and her life.”

And so, Adi began a long series of operations. The last was only a few months ago.

Articles in medical journals and text books tell the story of her miraculous recovery. But everyone knows that miracles do not happen in a vacuum. It takes a special team and a special hospital.

It took Adi a while to get her life organized after so much surgery, but she is now a university student, majoring in communications.

The night of her wedding, however, she is pure bride, as her dark hair frames her delicate features above the white dress. Her tall, handsome groom, Eliran Peretz, is waiting to put a ring on her finger.

A venerable Sephardic Rabbi pronounces the blessings. Her mother, Mali Houdja, is wiping her eyes.

The groom breaks the glass and recites: “If I forget thee Jerusalem….”

Tonight, Jerusalem is in no danger of being forgotten.

Cheers and laugher prevail. In the line-up to hug the bride, Adi’s cousins begin to shout: “Adi! Here’s Prof. Rivkind. Here’s Prof. Liebergall.”

The crowd parts for these precious hugs.

“And I hug Adi, too,” relates Mrs. Sofer. And I say,”This is the hug from 330,000 women and men of Hadassah. We’re all here with you tonight.”

Date: 3/7/2014

Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America